Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERT in Pancreaticoduodenectomy
NCT06119880Phase 4Recruiting
- Sponsor
- Ruijin Hospital
- Start
- Nov 2023
- Primary completion
- Dec 2024
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of pancreatin in pancreatic exocrine insufficiency (EPI), sponsored by Ruijin Hospital. Started Nov 2023; status: recruiting.
02
Drugs
pancreatin
03
Conditions
pancreatic exocrine insufficiency (EPI)
Beyond the preview
Go deeper on NCT06119880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06119880.